Search

Your search keyword '"Cosmina Nedelcu"' showing total 3 results
Start Over Author "Cosmina Nedelcu" Publisher springer science and business media llc
3 results on '"Cosmina Nedelcu"'

1. A multicenter comparative matched-pair analysis of percutaneous tumor ablation and robotic-assisted partial nephrectomy of T1b renal cell carcinoma (AblatT1b study—UroCCR 80)

Author

Grégoire Cazalas, Clément Klein, Gilles Piana, Eric De Kerviler, Afshin Gangi, Philippe Puech, Cosmina Nedelcu, Remi Grange, Xavier Buy, Marc-Antoine Jegonday, Pierre Bigot, Charles Karim Bensalah, Victor Gaillard, Géraldine Pignot, Philippe Paparel, Lionel Badet, Clément Michiels, Jean Christophe Bernhard, Olivier Rouviere, Nicolas Grenier, and Clément Marcelin

Subjects
Radiology, Nuclear Medicine and imaging, General Medicine
Published
2023
Full Text
View/download PDF

2. Prostate cancer detection by targeted prostate biopsy using the 3D Navigo system: a prospective study

Author

Samuel Chelly, Abdel Rahmene Azzouzi, Alexandre Magnier, Souhil Lebdai, Marie-Christine Rousselet-Chapeau, and Cosmina Nedelcu

Subjects
Image-Guided Biopsy, Male, medicine.medical_specialty, Prostate biopsy, Urology, Prostate cancer, Prostate, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Prospective Studies, Risk factor, Prospective cohort study, Aged, Ultrasonography, Aged, 80 and over, Radiological and Ultrasound Technology, medicine.diagnostic_test, business.industry, Ultrasound, Gastroenterology, Prostatic Neoplasms, Magnetic resonance imaging, Middle Aged, Hepatology, medicine.disease, Magnetic Resonance Imaging, medicine.anatomical_structure, business
Abstract

The 3D Navigo™ system is a magnetic resonance imaging (MRI) and transrectal ultrasound (TRUS) fusion device for prostate targeted biopsies (TB). Our aim was to evaluate the clinically significant prostate cancer (CSC) detection rate of TB using the 3D Navigo™ system. Patients who underwent TB with the 3D Navigo™ system in our center between June 2014 and May 2018 were prospectively included, excluding those who have previously received treatment for prostate cancer. A 3-Tesla MRI imaging was performed before biopsies; findings were reported according to the Prostate Imaging Reporting and Data System version 2 (PIRADS). CSC was defined by an ISUP score ≥ 2. 304 patients underwent TB. Median age was 66 years (51–84). Median PSA was 7.75 ng/ml (0.6–70.0). Median prostate volume was 45.0 ml (15.9–221.7). PCa and CSC were found in 70.4% (214/304) and 47.7% (145/304) of the patients, respectively. The proportion of patients diagnosed with CSC among those with PCa was 67.8% (145/214). There was a significant risk of having a CSC in case of PIRADS score ≥ 4 and 5 (OR 5.0, 95% CI [2.7–9.2], P

Published
2021
Full Text
View/download PDF

3. Contemporary assessment of the correlation between Bosniak classification and histological characteristics of surgically removed atypical renal cysts (UroCCR-12 study)

Author

Yves Allory, Gaëlle Fromont-Hankard, François Cornelis, Jean-Christophe Bernhard, Mokrane Yacoub, Sofiane Béjar, Véronique Lindner, Nathalie Rioux-Leclercq, Laurent Daniel, Nicolas Grenier, Arnaud Mejean, Karim Bensalah, Virginie Verkarre, Pierre Bigot, Zine-Eddine Khene, Cosmina Nedelcu, François-Xavier Nouhaud, Jean-Michel Correas, François Audenet, G. Fraisse, S. Bergerat, Herve Lang, Institut de recherche en santé, environnement et travail (Irset), Université d'Angers (UA)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), and Université d'Angers (UA)-Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique )

Subjects
Male, Nephrology, medicine.medical_specialty, Histology, Urology, 030232 urology & nephrology, Bosniak classification, [SDV.CAN]Life Sciences [q-bio]/Cancer, Renal cysts, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, medicine, Humans, Cyst, Stage (cooking), Carcinoma, Renal Cell, Computed tomography, Pathological, ComputingMilieux_MISCELLANEOUS, Aged, Neoplasm Staging, Retrospective Studies, Cysts, business.industry, Kidney Diseases, Cystic, Middle Aged, Prognosis, medicine.disease, Kidney Neoplasms, 3. Good health, Clear cell renal cell carcinoma, 030220 oncology & carcinogenesis, Female, Low malignant potential, Radiology, Neoplasm Recurrence, Local, Tomography, X-Ray Computed, business, Kidney cancer
Abstract

To evaluate and compare pathological characteristics of renal cysts Bosniak IIF, III and IV in light of recent histological classification. The French research network for kidney cancer UroCCR conducted a multicentre study on patients treated surgically for a renal cyst between 2007 and 2016. Independent radiological and centralized pathological reviews were performed for every patient. Pathological characteristics were compared to the Bosniak classification. Of a total 216 patients included, 175 (81.0%) tumours (90.9% of Bosniak IV, 69.8% of Bosniak III) were malignant or had a low malignant potential, with 60% of clear cell renal cell carcinoma (CCRCC), 24% of papillary RCC (PRCC) and 6.9% of multilocular cystic renal tumour of low malignant potential (MCRTLMP). Malignancies were mostly of low pT stage (86.4% of pT1–2), and low ISUP grade (68.0% of 1–2). Bosniak III cysts had a lower rate of CCRCC (46.7 vs. 67.3%), higher rate of PRCC (30 vs. 20.9%) and MCRTLMP (18.3 vs. 0.9%) compared to Bosniak IV (p

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results